Bohai Pharmaceuticals Group, Inc., through its subsidiaries, engages in the production, manufacture, and distribution of herbal pharmaceuticals based on traditional Chinese medicine in the People's Republic of China. It produces seven varieties of approved traditional Chinese herbal medicines comprising four prescription drugs and three over the counter products in seven delivery systems, including tablets, granules, capsules, formulations, concentrated powder, tincture, and medicinal wine for addressing rheumatoid arthritis, viral infections, gynecological diseases, cardio vascular issues, and respiratory diseases. The company's products include Lung Nourishing syrup to moisten the lung and relieve coughs; Tongbi capsules to promote blood circulation and relieve swelling and pain; Tongbi tablets to regulate and fortify the blood promote blood circulation and relieve swelling pain; Zhuangyuanshenhailong medicinal wine to promote kidney function; and BazhenYimu cream for menstruation conditioning. Its products also comprise Fangfengtongsheng granules to treat cold, fever, headache, constipation, measles, and eczema; and Zhengxintai capsules to improve kidney function and treat coronary artery disease and angina. The company sells its products through hospitals, local pharmacies, and retail drug store chains. Bohai Pharmaceuticals Group, Inc. is headquartered in Yantai, China.
- Yantai, China
Primary Stock Exchange Listings